Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT00640991 Completed - Clinical trials for Cardiovascular Diseases

REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)

RECREATE Pilot
Start date: April 2008
Phase: Phase 3
Study type: Interventional

Insulin will safely reduce glucose levels in patients with acute ST-elevation myocardial infarction and admission hyperglycemia.

NCT ID: NCT00639457 Completed - Obesity Clinical Trials

Exercise and Pioglitazone for HIV-Metabolic Syndromes

Start date: January 2005
Phase: N/A
Study type: Interventional

The purpose is to examine the safety and efficacy of 16wks of pioglitazone (Actos; 30mg/d) with and without aerobic and strength exercise training for reducing glucose intolerance and central adiposity in HIV-infected people. We anticipate that pioglitazone + exercise training will improve glucose metabolism and insulin sensitivity, and reduce central adiposity more than pioglitazone alone. These improvements should translate into reduced cardiovascular disease risk in HIV-infected people.

NCT ID: NCT00638976 Completed - Clinical trials for Cardiovascular Disease

INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial

INSTANT
Start date: November 2007
Phase: Phase 3
Study type: Interventional

Randomized, blind controlled, Multicenter, spontaneous, prospective trial, roughly 20 enrolling centers in Italy, placebo and active drug supply given by GlaxoSmithKline (GSK).

NCT ID: NCT00632840 Completed - Obesity Clinical Trials

Pharmacological Regulation of Fat Transport in Metabolic Syndrome

Start date: June 2001
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether atorvastatin and fenofibrate are effective in the treatment of lipid disorders in obese, insulin resistant subjects.

NCT ID: NCT00632021 Completed - Heart Failure Clinical Trials

Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)

PILL-CVD
Start date: May 2008
Phase: N/A
Study type: Interventional

Many people who have recently left the hospital have difficulties managing their medications, and medication errors are common. Patients with low health literacy levels may have a particularly difficult time understanding medication dosing and instructions. This study will evaluate a literacy-focused program that provides educational assistance from pharmacists at the time of hospital discharge to people hospitalized with heart problems.

NCT ID: NCT00631904 Completed - Clinical trials for Cardiovascular Disease

St. Mary's Duluth Clinic (SMDC) Pacemaker Magnetic Resonance Imaging (MRI) Study

Start date: January 2005
Phase: N/A
Study type: Observational

The purpose of this study is to monitor and follow non-pacemaker dependent patients with implanted permanent pacemakers, who undergo medically required Magnetic Resonance Imaging (MRI) scans. Patients with pacemakers are currently excluded from obtaining MRI scans. MRI scanning is now the imaging of choice for a number of neurological, vascular, or musculoskeletal conditions. Data suggests that patients with pacemakers, when properly monitored, can safely undergo MRI scanning, though the largest published study to date consists of 54 patients, and no long term follow-up has been published. Though MRI cardiac scanning has been demonstrated to produce local tissue heating at the pacemaker lead tip, the long term effect of tissue heating on lead stability is unclear. This study will evaluate patients with permanent pacemakers undergoing medically indicated MRI scanning. Patients will be followed for one year at 3, 6, and 12 months. Data collected will evaluate change in pacing thresholds over time as well as cardiac troponin I, creatinine kinase MB function, and myoglobin levels within the first 12 hours following the scans, side effects, symptoms, the need to make pacemaker program changes, and possible artifacts created by the pacemaker on the MRI scan.

NCT ID: NCT00631306 Completed - Atherosclerosis Clinical Trials

Effects of Cranberry Juice on Risk Factors for Cardiovascular Disease

Start date: February 2008
Phase: N/A
Study type: Observational

This study is being done to determine if the use of double strength cranberry juice in daily diet will improve endothelial function.

NCT ID: NCT00631046 Completed - Obesity Clinical Trials

Essential Fatty Acids During Complementary Feeding

EFiON
Start date: February 2008
Phase: N/A
Study type: Interventional

The objective of this intervention study is to examine the effect of n-3 LCPUFA on growth and body composition, intestinal health and microbiotic composition, immune function and risk markers for later diseases in 9-18 months old infants and toddlers.

NCT ID: NCT00629954 Recruiting - Clinical trials for Cardiovascular Diseases

Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases

AHS
Start date: November 2009
Phase: N/A
Study type: Observational

This is a multi-site prospective epidemiological investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.

NCT ID: NCT00627653 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function

PPAR
Start date: October 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if treatment with a drug called fenofibrate, which is a PPAR-alpha agonist and controls how the heart metabolizes fats, will reverse the age-related decline in cardiac fat metabolism and mechanical function.